Skip to main content

Pharmaceutical News and Articles

Comprehensive and up-to-date drug news for both consumers and healthcare professionals.

Yogurt Makers Can Make Limited Claims About Type 2 Diabetes Prevention: FDA

MONDAY, March 4, 2024 -- Yogurt makers can now make limited claims about the food's power to help prevent type 2 diabetes, the U.S. Food and Drug...

First Birth Control Pill Sold Over the Counter Hits Store Shelves Soon

MONDAY, March 4, 2024 -- The first over-the-counter birth control pill will soon be available in U.S. stores and online, the drug's maker plans to announce...

New Insights Into the Persistent Pain of UTIs

MONDAY, March 4, 2024 -- People with recurring urinary tract infections frequently have persistent pain, even after antibiotics have cleared the harmful...

More Evidence Sleep Apnea Harms Thinking, Memory

MONDAY, March 4, 2024 -- Sleep apnea could have detrimental effects on the brain, causing memory or thinking problems, a new study suggests.People suffering...

1 in 8 Seniors Who Undergo Surgery Are Back in Hospital Within a Month

MONDAY, March 4, 2024 -- Major surgery is a dicey proposition for many seniors, with a substantial number landing back in the hospital just weeks or months...

American Academy of Orthopaedic Surgeons, Feb. 12 to 16

The annual meeting of the American Academy of Orthopaedic Surgeons was held from Feb. 12 to 16 in San Francisco and attracted approximately 30,000 participants...

Behavioral Health Disorders Linked to Worse Outcomes After Cancer Surgery

FRIDAY, March 1, 2024 -- For patients with cancer, behavioral health disorders (BHD) are associated with worse outcomes, including long-term postoperative...

Prenatal Exposure to Antiseizure Meds May Not Increase Epilepsy Risk in Children

FRIDAY, March 1, 2024 -- The associations between prenatal exposure to certain antiseizure medications (ASMs) and epilepsy risk among children are attenuated...

Advantaged Households Have Lower Intent to Vaccinate Teens Against HPV

FRIDAY, March 1, 2024 -- A significant proportion of adolescents who are unvaccinated or not fully vaccinated against human papillomavirus (HPV) are from...

Prevalence of Arthritis in U.S. Adults 18.9 Percent in 2022

FRIDAY, March 1, 2024 -- The age-adjusted prevalence of adults with arthritis was 18.9 percent in 2022 in the United States, according to a February data brief...

Minerva Neurosciences Receives Complete Response Letter from FDA for New Drug Application for Roluperidone for the Treatment of Negative Symptoms in Patients with Schizophrenia

BURLINGTON, Mass., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the...

FDA Approves Exblifep (cefepime/enmetazobactam) for the Treatment of Complicated Urinary Tract Infections

SAINT-LOUIS, France & WEILL AM RHEIN, Germany February 27, 2024 -- Allecra Therapeutics (“Allecra”), a biopharmaceutical company developing...

U.S. FDA Approves Expanded Indication for Gilead’s Biktarvy to Treat People with HIV with Suppressed Viral Loads, Pre-Existing Resistance

FOSTER CITY, Calif.--(BUSINESS WIRE) February 26, 2024 -- Gilead Sciences, Inc. (Nasdaq: GILD) today announced the U.S. Food and Drug Administration (FDA)...

Johnson & Johnson Announces Expansion of Imbruvica (ibrutinib) Label in the U.S. to Include Oral Suspension Formulation for Adult Patients in its Approved Indications

HORSHAM, PA. February 26, 2024 – Johnson & Johnson, in collaboration with its alliance partner, Pharmacyclics LLC, an AbbVie Company, announced today...

FDA Approves Simlandi (adalimumab-ryvk), an Interchangeable Biosimilar to to Humira

REYKJAVIK, Iceland and PARSIPPANY, N.J., Feb. 24, 2024 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO) and Teva Pharmaceuticals, a U.S. affiliate of Teva...

Venatorx and Melinta Provide Update on Status of U.S. New Drug Application for Cefepime-Taniborbactam

Malvern, PA, and Parsippany, NJ – February 23, 2024 – Venatorx Pharmaceuticals (Venatorx) and Melinta Therapeutics (Melinta) announced today that...

Linvoseltamab BLA for Treatment of Relapsed/Refractory Multiple Myeloma Accepted for FDA Priority Review

TARRYTOWN, N.Y., Feb. 21, 2024 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration...

Tecvayli (teclistamab-cqyv) Biweekly Dosing Approved by the U.S. FDA for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma

HORSHAM, Pa., Feb. 20, 2024 /PRNewswire/ -- Johnson & Johnson announced today that the U.S. Food and Drug Administration (FDA) has approved the...

FDA and EMA Accept Vorasidenib Regulatory Submissions for the Treatment of IDH-mutant diffuse glioma

Boston, MA, Suresnes, France, February 20 2024 – Servier, a global leader in oncology focused on delivering meaningful therapeutic progress for the...

Datopotamab Deruxtecan Biologics License Application Accepted in the US for Patients with Previously Treated Advanced Nonsquamous Non-Small Cell Lung Cancer

Application based on results from the TROPION-Lung01 Phase III trial If approved, AstraZeneca and Daiichi Sankyo’s datopotamab deruxtecan may be the...

SciSparc Delivers Treatment for Autism Spectrum Disorder Clinical Trial Enabling Commencement of Dosing

TEL AVIV, Israel, Feb. 29, 2024. SciSparc Ltd. ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of...

Palatin Announces Results of PL9643 MELODY-1 Pivotal Phase 3 Clinical Trial in Patients with Dry Eye Disease (DED)

CRANBURY, N.J., Feb. 28, 2024 -- Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on...

Lutris Pharma Receives FDA Orphan Drug Designation for LUT014 for the Treatment of EGFRI-Induced Acneiform Rash

Feb. 28, 2024 -- Lutris Pharma, a clinical stage biopharmaceutical company focused on improving anti-cancer therapies by reducing dose limiting side effects...

Smoking Cannabis Associated with Increased Risk of Heart Attack, Stroke

February 28, 2024 -- Frequent cannabis smoking may significantly increase a person’s risk for heart attack and stroke, according to an observational...

Incannex Announces Positive Topline Results from Phase 2 Psi-GAD1 Clinical Trial of Psilocybin in Generalised Anxiety Disorder

MELBOURNE, Australia and NEW YORK, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL), (Incannex or the Company), a leading cannabinoid...

Browse by news type

Drugs.com Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.

Disclaimer

This library contains syndicated news articles. These articles have not been peer-reviewed by Drugs.com, and therefore we cannot guarantee accuracy to the highest ethical standards. Do further research as needed. Consultation with your physician is essential.